- Home
- CRSR vs NEO Comparison
CRSR vs NEO Comparison
Compare CRSR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRSR
- NEO
- Stock Information
- Founded
- CRSR 1994
- NEO 2001
- Country
- CRSR United States
- NEO United States
- Employees
- CRSR N/A
- NEO N/A
- Industry
- CRSR Computer Manufacturing
- NEO Precision Instruments
- Sector
- CRSR Technology
- NEO Health Care
- Exchange
- CRSR Nasdaq
- NEO Nasdaq
- Market Cap
- CRSR 1.1B
- NEO 965.2M
- IPO Year
- CRSR 2020
- NEO 1999
- Fundamental
- Price
- CRSR $9.03
- NEO $7.00
- Analyst Decision
- CRSR Buy
- NEO Buy
- Analyst Count
- CRSR 6
- NEO 9
- Target Price
- CRSR $10.00
- NEO $13.31
- AVG Volume (30 Days)
- CRSR 571.5K
- NEO 2.0M
- Earning Date
- CRSR 07-31-2025
- NEO 07-28-2025
- Dividend Yield
- CRSR N/A
- NEO N/A
- EPS Growth
- CRSR N/A
- NEO N/A
- EPS
- CRSR N/A
- NEO N/A
- Revenue
- CRSR $1,348,872,000.00
- NEO $672,361,000.00
- Revenue This Year
- CRSR $14.40
- NEO $13.97
- Revenue Next Year
- CRSR $9.76
- NEO $11.36
- P/E Ratio
- CRSR N/A
- NEO N/A
- Revenue Growth
- CRSR N/A
- NEO 10.10
- 52 Week Low
- CRSR $5.60
- NEO $6.08
- 52 Week High
- CRSR $13.02
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- CRSR 52.79
- NEO 40.74
- Support Level
- CRSR $9.00
- NEO $6.90
- Resistance Level
- CRSR $9.49
- NEO $7.42
- Average True Range (ATR)
- CRSR 0.34
- NEO 0.39
- MACD
- CRSR -0.07
- NEO -0.00
- Stochastic Oscillator
- CRSR 38.46
- NEO 13.01
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.